Novo Nordisk has tested a more effective weight loss treatment

Date:

Share this article:

Del denne artikel:

A large-scale trial of a new combination drug for type 2 diabetes may influence future treatment options.

Novo Nordisk has applied for approval in the United States for the drug CagriSema as a weight loss treatment in combination with diet and exercise.

If approved, it could be used in the same way as Wegovy.

At the same time, the company plans to test the medication against tirzepatide from Eli Lilly.

The market for this type of treatment is developing rapidly, with several companies competing to produce the most effective drugs.

Also read: Trump’s preferred sport is shared with his granddaughter Kai

The results come from the phase 3 trial REIMAGINE 2, which has not yet been published in a scientific journal, according to Medical News Today.

Results from the study

The trial included 2,728 people with type 2 diabetes who had not achieved sufficient results with metformin.

At the start, participants had an average long-term blood sugar (HbA1c) level of 8.2 percent and an average weight of 101 kilograms.

Over 68 weeks, participants received either CagriSema, the individual components administered separately, or a placebo.

Also read: Actor’s death brings renewed focus to colorectal cancer symptoms

According to Novo Nordisk’s data reported by Medical News Today, long-term blood sugar levels decreased by 1.91 percentage points in those who received the highest dose of CagriSema.

Among those who received semaglutide alone, the reduction was 1.76 percentage points.

Body weight decreased by an average of 14.2 percent with CagriSema, compared with 10.2 percent with semaglutide alone.

What does the medication contain?

CagriSema combines semaglutide and cagrilintide. Both substances affect hormones that regulate appetite, satiety, and blood sugar levels.

Also read: New research: Bedroom temperature affects the heart

An independent expert interviewed by Medical News Today emphasized that the results come from the manufacturer itself.

Further independent studies are therefore needed to assess effectiveness and side effects.

Only with additional documentation will it be possible to determine whether the treatment is genuinely superior to current options.

Sources: Medical News Today.

Also read: Doctor reveals when you should stop drinking coffee to sleep better

Also read: No gym required: Nine cardio exercises you can do at home

This article is made and published by Ida-Marie Palm Varbæk, who may have used AI in the preparation.

Other articles

Your smartwatch may now catch a dangerous sleep condition most people miss

A new Stanford test of a device most of us already wear suggests it may spot something doctors often miss.

Using a sauna 4-7 times a week may cut fatal heart disease risk by half

The strongest effect only showed up at a certain weekly dose, and the length of each session seemed to matter as much.

Heart rate recovery by age: What your number says about your heart

The pulse count sixty seconds after you stop sweating may say more about your heart than your resting rate does.

7 warning signs of vitamin C deficiency most people write off as stress

The warning signs can show up months before anything looks obviously wrong, and most of them get blamed on stress or getting older.

Your smartwatch may now catch a dangerous sleep condition most people miss

A new Stanford test of a device most of us already wear suggests it may spot something doctors often miss.

Using a sauna 4-7 times a week may cut fatal heart disease risk by half

The strongest effect only showed up at a certain weekly dose, and the length of each session seemed to matter as much.

Heart rate recovery by age: What your number says about your heart

The pulse count sixty seconds after you stop sweating may say more about your heart than your resting rate does.